Eventide Asset Management, LLC Aura Biosciences, Inc. Transaction History
Eventide Asset Management, LLC
- $5.22 Billion
- Q4 2024
A detailed history of Eventide Asset Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 4,080,605 shares of AURA stock, worth $31.1 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
4,080,605
Previous 5,802,682
29.68%
Holding current value
$31.1 Million
Previous $51.7 Million
35.12%
% of portfolio
0.64%
Previous 0.91%
Shares
6 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
39.9MCall Options Held
1.9KPut Options Held
31K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$52.8 Million2.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$37.2 Million0.07% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$23.2 Million5.49% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$22.9 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR2.54MShares$19.4 Million0.71% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $223M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...